Study Design. A retrospective, observational study. Objective. The aim of this study was to determine the utilization of various treatment modalities in the management of degenerative spondylolisthesis within Medicare beneficiaries. Summary of Background Data. Degenerative lumbar spondylolisthesis is a condition often identified in symptomatic low back pain. A variety of treatment algorithms including physical therapy and interventional techniques can be used to manage clinically significant degenerative spondylolisthesis. Methods. This study utilized the 5% national sample of Medicare carrier claims from 2000 through 2011. A cohort of beneficiaries with a new International Classification of Diseases 9th edition (ICD-9) diagnosis code for degenerative lumbar spondylolisthesis was identified. Current procedural terminology codes were used to identify the number of procedures performed each year by specialty on this cohort. Results. A total of 95,647 individuals were included in the analysis. Average age at the time of initial diagnosis was 72.8 AE 9.8 years. Within this study cohort, spondylolisthesis was more prevalent in females (69%) than males and in Caucasians (88%) than other racial demographics. Over 50% of beneficiaries underwent at least one injection, approximately one-third (37%) participated in physical therapy, one in five (21%) underwent spinal surgery, and one-third (36%) did not utilize any of these interventions. Greater than half of all procedures (124,280/216,088) occurred within 2 years of diagnosis. The ratio of focal interventions (transforaminal and facet interventions) to less selective (interlaminar) procedures was greater for the specialty of Physical Medicine and Rehabilitation than for the specialties of Anesthesiology, Interventional Radiology, Neurosurgery, and Orthopedic Surgery. The majority of physical therapy was dedicated to passive treatment modalities and range of motion exercises rather than active strengthening modalities within this cohort. Conclusion. Interventional techniques and physical therapy are frequently used treatment modalities for symptomatic degenerative spondylolisthesis. Understanding utilization of these techniques is important to determine relative clinical efficacies and to optimize future health care expenditures.
D
egenerative lumbar spondylolisthesis is a spinal instability that results from progressive degeneration of the facet joints, intervertebral discs, and ligamentous structures without disruption of the posterior vertebral ring. 1 The condition is defined as the anterior subluxation of one vertebra in relation to the next caudal vertebra and occurs most frequently at the L4 to L5 level. [2] [3] [4] Degenerative spondylolisthesis is often asymptomatic but can present clinically as symptomatic axial low back pain, radicular pain, or neurogenic claudication, as it is associated A variety of treatment algorithms including physical therapy and other interventional techniques can be used to manage clinically significant degenerative spondylolisthesis. However, the most recent North American Spine Society Clinical Guidelines could not adequately determine the effectiveness of medical and other nonsurgical interventions to treat degenerative spondylolisthesis due to insufficient evidence-based studies. 11 A lack of consensus on the appropriate nonsurgical treatment algorithm for this condition has resulted in highly varied practices among providers. 9 Physical therapy prescriptions may focus on passive therapeutic modalities such as heat, ultrasound, massage, and manual traction or may alternatively stress active modalities of muscular strengthening and stabilization training. Spinal injection procedures include focal options to diagnostically isolate and treat the putative pain generators (transforaminal epidural injections, facet interventions) and less-specific treatment options such as interlaminar and caudal epidural injections. Some research suggests that using transforaminal injections and active physical therapy modalities may be especially beneficial and delay the need for surgical intervention to treat spondylolisthesis. 12, 13 However, surgical interventions including decompression or arthrodesis procedures are available if nonoperative modalities are unsuccessful.
The aims of this study were (1) to evaluate the incidence of degenerative spondylolisthesis within Medicare beneficiaries from 2000 through 2011, and (2) to describe the utilization of spinal interventional techniques, surgical interventions, and physical therapy within this newly diagnosed population.
MATERIALS AND METHODS
To allow for feasible data analysis, this study utilized an initial cohort composed of the standard 5% sample of all patients with ICD-9 codes for back pain recorded in the Medicare Carrier files, from 2000 to 2011. This database has been utilized previously to track subjects over time and is considered a good representation of the overall Medicare population. 14, 15 Medicare covers the cost of health care services, including medically indicated surgeries, to US citizens who are at least 65 years in age, have been permanently disabled for at least two years, or are on dialysis. Beneficiaries of all age groups were included. This research was granted an exemption from institutional review board review.
A previously validated coding definition model was utilized to determine all inclusion and exclusion ICD-9 codes. 15 Beneficiaries with a new diagnosis of degenerative lumbar spondylolisthesis were isolated through a two-step process. First, all subjects assigned a primary or secondary ICD-9 diagnosis code for degenerative lumbar spondylolisthesis (738.4, 756.12) were extracted from the initial cohort. Second, this subpopulation was refined to determine the initial use of these diagnosis codes by eliminating all subjects with an association of a spondylolisthesis ICD-9 code to a billable office visit, therapy session, imaging study, or procedure during the previous 365-day period Similarly, CPT codes were utilized to identify surgical interventions performed on this subset of beneficiaries. The frequency of three types of surgical intervention was investigated. Dorsal column stimulator placements were isolated using CPT code 63650. Standalone decompression procedures were isolated using the following CPT codes without additional CPT codes for instrumentation or fusion substrate within 14 calendar days: 63005 (lumbar laminectomy without facetectomy, foraminotomy or discectomy, 1 or 2 segments), 63017 (more than two segments), 63012 (lumbar laminectomy for spondylolisthesis with removal of abnormal facet or pars interarticularis), 63030 (lumbar laminotomy including partial facetectomy, foraminotomy, and/or excision of herniated disc), 63035 (each additional interspace), 63042 (re-exploration lumbar laminotomy, including partial facetectomy, foraminotomy, and/or excision of herniated disc), 63044 (each additional interspace), 63047 (lumbar laminectomy, facetectomy and foraminotomy, single level), 63048 (each additional segment). The frequency of arthrodesis procedures was identified through either designation of a specified lumbar fusion CPT code or by the presence of a standalone decompression CPT code along with an additional CPT code for lumbar instrumentation or fusion substrate within 14 calendar days. Lumbar arthrodesis CPT codes utilized were 22558 (anterior lumbar interbody fusion, first interspace), 22585 (anterior lumbar interbody fusion, additional interspace), 22612 (lumbar posterolateral fusion, first level), 22614 (each additional segment), 22630 (posterior lumbar interbody fusion, first interspace), 22632 (each additional interspace), 22633 (combined fusion, posterolateral fusion, with posterior interbody fusion, first segment), 22634 (each additional segment). Instrumentation/fusion substrate CPT codes were 22840 (posterior nonsegmental instrumentation), 22842 (posterior segmental instrumentation, three to six segments), 22843 (7-12 segments), 22844 (13þ segments), 22845 (anterior instrumentation, two to three segments), 22846 (four to seven segments), 22847 (eight or more segments), 22851 (application of biomechanical device, first interspace), 20930 (allograft, morselized), 22931 (allograft, structural), 20936 (autograft, same incision), 20937 (autograft morselized, separate incision), 20938 (autograft structural, separate incision).
Current billing codes for several modalities of physical therapy from 2000 to 2011 were used to identify the number of procedures performed each year on this cohort, using the CMS Carrier file. 
RESULTS
A total of 95,647 individuals with a new diagnosis of degenerative spondylolisthesis were included in the analysis after exclusion criteria were applied. Average age at the time of initial diagnosis was 72.8 AE 9.8 years (range 21-104 yrs). Within this population, the male to female ratio of a new diagnosis was 1 : 2.2. Caucasians represented 87.8% of newly diagnosed beneficiaries compared with 7.6% for self-reported African Americans (Table 1) . Greater than 50% of beneficiaries included in this analysis underwent at least one injection over the study period. Approximately one-third (37%) participated in physical therapy, one in five (21%) underwent spinal surgery, and one-third (36%) did not utilize any of these interventions ( Table 2) .
There were 216,088 total procedures performed on 53,297 beneficiaries within this cohort over the study period (4.1 procedures per treated individual). Injection therapy was most frequently utilized (0.94 injections performed per patient) during the initial year of a degenerative spondylolisthesis diagnosis. Utilization sharply decreased to 0.42 injections per patient the second year after diagnosis and continued to downtrend over each subsequent year ( Figure 1A) . Overall, greater than half of all procedures (58%) occurred within 2 years of diagnosis. The utilization of each injection technique by postyear diagnosis is illustrated in Table 3 .
An interlaminar or caudal injection technique was performed on 24.6% of the beneficiaries over the course of this study. A transforaminal epidural approach was performed on 21.1% of beneficiaries with 12.6% undergoing a multilevel transforaminal procedure within 10 years of a degenerative spondylolisthesis diagnosis. Trigger point injections (7.5%), sacroiliac injections (6.0%), facet or medial branch blocks (4.1% initial level, 3.4% multilevel), and radiofrequency ablations (3.4% initial level, 3.3% multilevel) were also frequently utilized in this patient population (Figure 2) .
A subanalysis of utilization by injection type was performed on three distinct groups of billing providers. Physical Medicine and Rehabilitation specialists performed 35,141 (16%) total procedures and Anesthesiologists performed 77,353 (36%) total procedures on the beneficiaries. The third group, which was composed of Interventional Radiologists, Neurosurgeons, and Orthopedic Surgeons (INOS), Figure 3 ). There were 57,596 initial evaluations for physical therapy performed within this cohort ( Table 4) (Table 4) . Physical therapy was most frequently utilized during the initial year of diagnosis (6.1 billing units/ beneficiary). Similar to interventional techniques, utilization of physical therapy down trended with each subsequent year after the first year of diagnosis ( Figure 1B) .
Lumbar arthrodesis was performed on 14,563 beneficiaries. Approximately 69% (11,185) of these individuals underwent arthrodesis within one year of initial diagnosis. A standalone lumbar decompression procedure (without arthrodesis) was performed on 5646 subjects and a dorsal column stimulator was placed in 958 newly diagnosed individuals over the study period.
DISCUSSION
An initial diagnosis of degenerative spondylolisthesis was commonly assigned to Medicare beneficiaries. The aggregate number of beneficiaries from 2000 through 2011 with a newly diagnosed spondylolisthesis can be estimated to be approximately 1.9 million individuals after multiplying the frequency of diagnosis in the 5% sample by a factor of 20. As average Medicare enrollment was 48 million individuals over the period of this study, approximately 4% of all beneficiaries received a new diagnosis of degenerative spondylolisthesis. 16 The incidence of degenerative spondylolisthesis within this cohort was more than two-fold higher in females than in males. Several epidemiologic studies of degenerative spondylolisthesis have reported higher disease prevalence in the female population. 6, [17] [18] [19] [20] These studies report male to female anterolisthesis prevalence ratios that range from 1 : 1.6 to 1 : 6.4. Proposed mechanisms for this gender disparity include relative generalized joint laxity in females compared with males as well as a possible association with pregnancy, oophorectomy, and postmenopausal status. 6, 17, 19, 20 Other studies have implicated that paraspinal muscular development may contribute to increased prevalence among females. 18 Kalichman et al. 18 compared lumbar paraspinal muscle density in individuals with a degenerative lumbar spondylolisthesis and compared the value to individuals who did not have a lumbar deformity within the Framingham Study. These authors reported that female sex, increased body mass index (BMI), and advanced age were all associated with decreased multifidus and erector spinae density. Furthermore, they described a significant relationship between decreased multifidus density and an increased rate of anterolisthesis. 18 The percentage of degenerative anterolisthesis among white and black racial groups in this study is proportionally consistent with the racial composition of the United States geriatric population reported by the 2006 Census. 21 However, several epidemiologic studies have reported an increased prevalence of degenerative anterolisthesis in black individuals. Rosenberg et al. reported that the ratio of degenerative anterolisthesis in black women compared with white women was 3 to 1 within their study cohort. These authors proposed two possible mechanisms for this disparity. First, they described a comparatively higher frequency of L5 sacralization in black individuals. This variation increases lumbosacral stability and results in distribution of greater magnitude biomechanical forces to the L4 to L5 level. Second, these authors proposed that increased prevalence of anterolisthesis among black individuals could be a result of more frequent absence of accessory processes for ligamentous attachments at the fourth lumbar vertebral level and less overall slope between anterior and posterior aspects of the vertebral body (2.1 mm) compared with nonblack comparison groups (6 mm). 5 The lower than expected proportion of newly diagnosed degenerative spondylolisthesis among reported black beneficiaries indicates that these individuals may have less access to medical resources or may face other cultural and socioeconomic barriers to seeking medical care.
Medicare-wide expenditures on spinal injection techniques increased 186% per 100,000 beneficiaries from 2000 to 2008. 22 The results of our study demonstrate that a large volume of Medicare resources are apportioned specifically to treating symptomatic degenerative Many studies have described the clinical benefit of strengthening the lumbar paraspinal and truncal musculature in patients presenting with low back pain. 12, [23] [24] [25] [26] However, the majority of physical therapy was dedicated to passive treatment modalities and range of motion exercises within this cohort. This finding may indicate that patients were unable to tolerate the increased demand of active therapy modalities secondary to low back pain or radiating symptoms. In addition, this finding could reflect a deficiency of provider education or interdisciplinary communication between the prescribing physician and physical therapist.
There are a number of inherent limitations to this study. First, this is a descriptive analysis that relies on billing metrics and demographic information within the Medicare database. Although previous studies have determined that degenerative spondylolistheses are rare before the sixth decade of life, only a few younger individuals were included in the cohort. 5, 6 There is limited sociodemographic information captured within the database and we could not assess how factors such as smoking status or educational level impacted our findings. Furthermore, the availability of health-related quality of life data would allow more sensitive analysis of clinical outcomes after each category of intervention. Second, the accuracy of our analysis is dependent on proper and consistent coding among providers. Analytical errors could have been introduced if a provider improperly associated the degenerative spondylolisthesis diagnosis code with a procedure that was actually performed for an unassociated adjacent level pathology. In addition, the spondylolisthesis code may have been omitted and substituted with another diagnosis code (such as lumbar spondylosis) when procedures were performed predominantly for axial low back pain. These omissions would lead to a misclassification bias that yields an underestimation of the true incidence of degenerative spondylolisthesis within the Medicare population. Third, the ICD-9 code for degenerative spondylolisthesis does not distinguish subluxation severity. As a result, the data could not be stratified to distinguish the rate of surgery based on deformity progression. Overall, this study demonstrates that spinal injection techniques and physical therapy are frequently used as a treatment modality for symptomatic degenerative spondylolisthesis. Anatomically selective intervention is utilized with varying frequency depending on provider specialty. Future studies will investigate the clinical impact of injection selectivity and the various modalities of physical therapy. Understanding utilization of these techniques is important to determine relative clinical efficacies and to optimize future health care expenditures.
Key Points
Roughly 1.9 million Medicare beneficiaries were newly diagnosed with degenerative lumbar spondylolisthesis from 2000 to 2011. A large volume of Medicare resources are apportioned to treating symptomatic degenerative spondylolisthesis. Over 50% of beneficiaries included in this analysis underwent at least one injection, approximately one-third (37%) participated in physical therapy, one in five (21%) underwent spinal surgery, and one-third (36%) did not utilize any of these interventions over the study period. A greater proportion of therapy time was spent performing passive modalities than active modalities of truncal strength and stabilization exercises. Anatomically selective intervention is utilized with varying frequency depending on provider specialty.
